E-ISFA 2020 Announcement

3rd Congress of the European Group – International Society for Apheresis (E-ISFA)

Dresden, March 19 to 21, 2020

Congress Topics

• Recent progress in lipoprotein apheresis
  • Homozygous familial hypercholesterolemia
  • Lipoprotein(a)
  • Competition with drugs
• Plasma exchange
• Immunoadsorption – indications, results, future perspectives
• Experience with extracorporeal therapy in children and during pregnancy
• Apheresis Registries
• How to assure the quality of care in extracorporeal therapy
• Psychosocial aspects in patients undergoing extracorporeal therapy
• Apheresis in transplantation
• New developments
  • Specific elimination of C-reactive Protein
    • After myocardial infarction, after other diseases
  • Other new devices
• Extracorporeal Photopheresis
• Cellular Therapies
• Actual aspects of lipid-lowering therapy
  • New data on PCSK9 inhibitors
  • Antisense oligonucleotides against apolipoprotein CIII and apolipoprotein(a)
  • Bempedoic acid – current status
  • New preparations of omega-3 fatty acids
  • Lomitapide
  • Latest study data

Further activities

• Sessions for medical staff (mostly in German)
  • Role of the medical staff in an Apheresis center
  • Psychological aspects
  • Venous access problems
  • Problems when treating children
  • Different apheresis methods – advantages, disadvantages
  • Other developments
• Special sessions organized by the industry (experience with apheresis devices, actual recommendations, troubleshooting)
• Actual topics in lipidology (in German, on Friday, March 20, 2018 in the afternoon, free entrance to all people wishing to attend)

Further information will follow in spring 2019